Collectively, our data revealed that PRP19 plays a critical role in B cell immune dysfunction via mediating DDX5 and CXCL12 levels, and is clinically associated with poor prognosis of HCC (Figure 8H). The gene discussed is DDX5; the disease is hepatocellular carcinoma.